Tirzepatide is a research peptide that acts as a GIP/GLP-1 receptor agonist, targeting both the glucose-dependent insulinotropic polypeptide (GIP) receptors and the glucagon-like peptide-1 (GLP-1) receptors. This dual-action mechanism helps decrease blood sugar levels by enhancing insulin production and reducing the amount of sugar produced by the liver. Additionally, Tirzepatide slows the rate at which food passes through the body, prolonging the feeling of fullness, which may aid in weight loss.